Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients With Heparin Resistance

NCT01734252 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT01734252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01734252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients With Heparin Resistance
Lead sponsor
Medical University Innsbruck
Phase
Phase 2
Overall status
Completed
Start date
July 29, 2012
Completion date
April 1, 2016
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

achievement of a sufficient thrombosis prohpylaxis in clitically ill patients with heparin resistance